Y2C
Long

IMMU Double Bottom

NASDAQ:IMMU   IMMUNOMEDICS INC
10 0 0
News out: Patients see significant and durable tumor shrinkage after receiving treatments with sacituzumab govitecan
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out